Lv2
200 积分 2022-06-06 加入
Real-world Outcomes and Tolerability of JAK Inhibitors in Chronic Spontaneous Urticaria and Chronic Inducible Urticaria: A Single-center Retrospective Study
5天前
已关闭
Efficacy and safety of the oral Janus kinase 1 inhibitor povorcitinib in patients with extensive vitiligo in a phase 2, randomized, double-blinded, dose-ranging, placebo-controlled study
2个月前
已完结
Efficacy and safety of the oral Janus kinase 1 inhibitor povorcitinib in patients with extensive vitiligo in a phase 2, randomized, double-blinded, dose-ranging, placebo-controlled study
3个月前
已完结
Efficacy and safety of the oral Janus kinase 1 inhibitor povorcitinib (INCB054707) in patients with hidradenitis suppurativa in a phase 2, randomized, double-blind, dose-ranging, placebo-controlled study
3个月前
已完结
Psychometric Properties and Meaningful Change Thresholds of the Vitiligo Area Scoring Index
4个月前
已完结
Recent Advances in Construction of Nitrogen-containing Heterocycles from Baylis-Hillman Adducts
4个月前
已完结
Expert consensus on the systemic treatment of atopic dermatitis in special populations
4个月前
已完结
Organelle-specific signaling of cGAS–STING
4个月前
已完结
Meaningful Changes in What Matters to Individuals with Vitiligo: Content Validity and Meaningful Change Thresholds of the Vitiligo Area Scoring Index (VASI)
4个月前
已完结
Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial
4个月前
已完结
皖公网安备34019202002308
